Protagonist Therapeutics
PTGX
$24.66
Share price
-4.05%
Change (1 day)
6.06%
Change (1 year)
Categories
Earnings for Protagonist Therapeutics (PTGX)
Earnings in 2023 (TTM): -$78.96 M
According to Protagonist Therapeutics 's latest financial reports the company's current earnings (TTM) are -$78.96 M. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$0.13 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Protagonist Therapeutics from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$78.96 M | -38.02% |
| 2022 | -$0.13 B | 1.47% |
| 2021 | -$0.13 B | 93.62% |
| 2020 | -$64.85 M | -16.74% |
| 2019 | -$77.88 M | 96.06% |
| 2018 | -$39.73 M | 7.48% |
| 2017 | -$36.96 M | -0.59% |
| 2016 | -$37.18 M | 150.22% |
| 2015 | -$14.86 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 40.31% | 🇺🇸 USA |